Omni-media health education combined with nanodrug therapy on the creation of gastrointestinal microenvironment and the improvement of treatment compliance in patients with gastrointestinal tumors

Prev Med. 2023 Aug:173:107567. doi: 10.1016/j.ypmed.2023.107567. Epub 2023 Jun 5.

Abstract

According to the randomization method, 82 patients can be divided into two groups, the control group and the study group, each with 41 patients participating in the investigation. All patients in the control group were cared for, and the study group used a health education model. The treatment mode of each group needs to adopt adherence, and it is necessary to maintain a healthy diet, smoking cessation and alcohol cessation, and regular review during the treatment of regular exercise and emotional regulation. To enable patients to accurately grasp health knowledge during treatment, score self-management ability (ESCA), and maintain a level of satisfaction with care. (1) In the study group, the standard treatment of patients directly reached 97.56%, regular review reached 95.12%, regular exercise reached 90.24%, the degree of smoking cessation reached 92.68%. (2) The mastery of disease and health knowledge in the first group (95.12%) was significantly higher than that of (78.05%) (P < 0.05). (3) After the intervention, the first group scored higher for self-responsibility (27.07 ± 3.15), self-awareness (25.59 ± 3.11), health knowledge (40.38 ± 4.54), and self-care skills (36.45 ± 3.19). (4) The nursing satisfaction level of the first group was (92.68%), which was significantly higher than that of the other group (75.61%). According to the conclusions, it can be shown that health education for tumor patients can improve patients' compliance with treatment and mastery of disease health knowledge, which is conducive to improving patients' self-management ability.

Keywords: Gastrointestinal microenvironment; Gastrointestinal tumors; Nanodrug therapy; Omnimedia health education; Treatment compliance.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Gastrointestinal Neoplasms*
  • Health Behavior
  • Health Education
  • Humans
  • Nanoparticles* / therapeutic use
  • Patient Compliance
  • Tumor Microenvironment